A Phase II Study of IL-6 Receptor Blockade to Ameliorate Acute Graft Versus Host Disease and Early Toxicity After Double Unit Cord Blood Transplantation in Adults With Hematologic Malignancies
Latest Information Update: 07 Mar 2024
At a glance
- Drugs Tocilizumab (Primary) ; Ciclosporin; Filgrastim; Mycophenolate mofetil
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 01 Mar 2024 Planned End Date changed from 7 Feb 2024 to 7 Feb 2025.
- 01 Mar 2024 Planned primary completion date changed from 7 Feb 2024 to 7 Feb 2025.
- 16 Mar 2023 Planned End Date changed from 7 Feb 2023 to 7 Feb 2024.